Advertisement

Topics

Neurodyn Cognition Inc. Company Profile

13:49 EDT 19th April 2018 | BioPortfolio

NCI is a private Canadian biotech company developing Memogain, a patented prodrug of an approved treatment for Alzheimer’s disease, galantamine (Reminyl®). Memogain’s intranasal administration achieves higher dose levels, with significantly greater brain bioavailability, while avoiding the compliance impairing gastro-intestinal adverse effects of existing symptomatic treatments. In addition to improved cognition the increased brain concentrations enhances the drugs unique and safe mechanism of sensitization of neuronal nicotinic acetylcholine receptors, most notably the alpha-7 subtype, which could result in the potential for disease modifying neuroprotective effects.


News Articles [95 Associated News Articles listed on BioPortfolio]

Neurodyn Appoints Anthony J. Giovinazzo as Director and Executive Chairman

Neurodyn Cognition Inc. (“NCI” or the “Company”), is pleased to announce the appointment of Anthony Giovinazzo as a director and Executive Chairman of the Company. NCI is ...

Cognition Corporation Announces Appointment of New CTO

Mitch Hayes Resigns from Cognition, David Taylor Appointed New CTO LEXINGTON, Mass. (PRWEB) December 13, 2017 Cognition Corporation, a software company specializing in medical device compliance and c...

Cambridge Cognition surges on contract win and funding award

Cambridge Cognition will deliver the study's cognitive assessments, patient-reported outcomes and clinician-reported outcomes on its CANTAB Connect cloud software.

Medical News Today: Can playing 'shoot-em-up' style video games boost cognition?

Researchers in Switzerland have revealed that a specific type of video game may help to boost cognition. Perhaps games could be tailored for this purpose.

New Cognition Corporation Case Study Released

Study Shows Impact of Cognition's IDE for Configuration Management Within its Cockpit Platform Lexington, Massachusetts (PRWEB) March 07, 2018 Cognition Corporation, a software company specializi...

Inadequate evidence for OTC supplements in preventing cognitive decline

1. There was inadequate evidence that any over-the-counter (OTC) supplement helped to prevent or delay decline in cognition. 2. The authors recommend further research using larger scale trials and cli...

Cognition Corporation Releases New Case Study

New Study Details Templated Design Controls/Risk Management and Benefits (PRWEB) November 07, 2017 Cognition Corporation, a software company specializing in medical device compliance and commercializ...

Inadequate evidence for over-the-counter supplements preventing cognitive decline

1. There was inadequate evidence that any over-the-counter (OTC) supplement helped to prevent or delay decline in cognition. 2. The authors recommend further research using larger scale trials and cli...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Lyrica [St Marys Medical Park Pharmacy]

These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral ...

PubMed Articles [352 Associated PubMed Articles listed on BioPortfolio]

Characterization of social cognition impairment in multiple sclerosis.

Multiple sclerosis (MS) has been associated with deficits in social cognition. However, little is known about which domains of social cognition are predominantly affected and what other factors are as...

A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).

Schizophrenia is marked by a global cognitive impairment that contributes significantly to chronic disability and unemployment. As new treatments are developed for cognition in schizophrenia, clinicia...

Visual Communication and Cognition in Everyday Decision-Making.

Understanding cognition and the context of decision-making should be prioritized in the design process in order to accurately anticipate the outcome for intended audiences. A thorough understanding of...

Neuro-cognition and social cognition elements of social functioning and social quality of life.

Previous studies have shown that deficits in social cognition mediate the association between neuro-cognition and functional outcome. Based on these findings, the current study presents an examination...

Aerobic exercise is more effective than goal-based exercise for the treatment of cognition in Parkinson's disease.

Little is known about how different exercise modalities influence cognition in Parkinson's disease (PD). Moreover, the focus of previous investigations on examining the effects of exercise mainly on e...

Clinical Trials [687 Associated Clinical Trials listed on BioPortfolio]

Effects of TENS in Pain During Application of Carboxytherapy in Patients With Gynoid Lipodystrophy

The project aims to compare the use of carboxiterapia ( therapeutic administration of carbon dioxide) with the use of active TENS and placebo TENS using the VAS scale as a parameter. The t...

Effects of H1-Antagonist on Cognition

The purpose of this study is to determine whether histamine is involved in memory and specific processes in human cognition.

Rehabilitation of Social Cognition in Subjects With Traumatic Brain Injury

In the present study we aim to analyze the performance in a battery of social cognition tests of subjects with traumatic brain injury. On the other hand, the effectiveness of a computeriz...

Efficacy of Social Cognition Training in Schizophrenia

The term social cognition refers to how social information is processed. Individuals with schizophrenia and schizoaffective disorder have been shown to have significant deficits in social ...

The Impact of Family Financial Support on Cognition

We have partnered with financial coaching organizations to establish what we have termed a "Medical-Financial Partnership (MFP)" that offers financial coaching to improve financial and men...

Companies [21 Associated Companies listed on BioPortfolio]

Neurodyn Cognition Inc.

NCI is a private Canadian biotech company developing Memogain, a patented prodrug of an approved treatment for Alzheimer’s disease, galantamine (Reminyl®). Memogain’s...

Neurodyn Inc.

Neurodyn Life Sciences Inc.

Cognition Therapeutics Inc.

Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disea...

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test ...

More Information about "Neurodyn Cognition Inc." on BioPortfolio

We have published hundreds of Neurodyn Cognition Inc. news stories on BioPortfolio along with dozens of Neurodyn Cognition Inc. Clinical Trials and PubMed Articles about Neurodyn Cognition Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neurodyn Cognition Inc. Companies in our database. You can also find out about relevant Neurodyn Cognition Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record